We are live on ! Find out more
SCP

Seizert Capital Partners Portfolio holdings

AUM $2.42B
1-Year Est. Return 22.12%
This Fund
S&P 500
This Quarter Est. Return
+17.59%
1 Year Est. Return
+22.12%
3 Year Est. Return
+73.42%
5 Year Est. Return
+88.59%
10 Year Est. Return
+355.73%
AUM
$1.48B
AUM Growth
+$117M
Cap. Flow
-$93.3M
Cap. Flow %
-6.32%
Top 10 Hldgs %
29.49%
Holding
235
New
47
Increased
42
Reduced
106
Closed
30

Top Buys

Rank Stock Value
1
ALSN icon
Allison Transmission
ALSN
+$18.3M
2
BAC icon
Bank of America
BAC
+$10.7M
3
JPM icon
JPMorgan Chase
JPM
+$10.1M
4
TT icon
Trane Technologies
TT
+$6.54M
5
COF icon
Capital One
COF
+$6.51M

Sector Composition

Rank Sector Weight
1 Technology 21.67%
2 Healthcare 17.94%
3 Financials 15.72%
4 Industrials 14.11%
5 Communication Services 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ODC icon
176
Oil-Dri
ODC
$1.34B
$229K 0.02%
13,194
-1,918
-13% -$33.2K
EBF icon
177
Ennis
EBF
$564M
$228K 0.02%
12,585
-8,280
-40% -$146K
EIGI
178
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$228K 0.02%
+56,606
New +$167K
ACU icon
179
Acme United Corp
ACU
$215M
$220K 0.01%
9,586
-1,394
-13% -$29.9K
SCSC icon
180
Scansource
SCSC
$1.12B
$219K 0.01%
9,074
-1,319
-13% -$31.2K
DHX icon
181
DHI Group
DHX
$173M
$214K 0.01%
101,868
-14,814
-13% -$38.1K
SXI icon
182
Standex International
SXI
$4.12B
$213K 0.01%
3,708
-540
-13% -$27.4K
CPRX
183
DELISTED
Catalyst Pharmaceutical
CPRX
$210K 0.01%
+45,508
New +$204K
CRHM
184
DELISTED
CRH Medical Corporation
CRHM
$209K 0.01%
+100,898
New +$204K
IMXI icon
185
International Money Express
IMXI
$367M
$208K 0.01%
+16,659
New +$169K
SRDX
186
DELISTED
Surmodics
SRDX
$207K 0.01%
4,786
-3,528
-42% -$134K
KMDA icon
187
Kamada
KMDA
$419M
$203K 0.01%
26,194
-17,485
-40% -$131K
BSTC
188
DELISTED
BioSpecifics Technologies Corp.
BSTC
$203K 0.01%
+3,312
New +$192K
SBT
189
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$197K 0.01%
+55,118
New +$181K
ACCS
190
ACCESS Newswire
ACCS
$26.2M
$191K 0.01%
+18,809
New +$189K
WNEB icon
191
Western New England Bancorp
WNEB
$275M
$183K 0.01%
31,640
+1,952
+7% +$10.8K
HBIO icon
192
Harvard Bioscience
HBIO
$29.2M
$159K 0.01%
5,124
-745
-13% -$20.1K
KBAL
193
DELISTED
Kimball International
KBAL
$153K 0.01%
13,210
-1,921
-13% -$21.9K
ARA
194
DELISTED
American Renal Associates Holdings, Inc
ARA
$148K 0.01%
+22,708
New +$147K
CLS icon
195
Celestica
CLS
$36.5B
$146K 0.01%
+21,330
New +$122K
NX icon
196
Quanex
NX
$1.01B
$144K 0.01%
+10,402
New +$124K
LYTS icon
197
LSI Industries
LYTS
$924M
$136K 0.01%
+20,972
New +$121K
PCOM
198
DELISTED
Points.com Inc. Common Shares
PCOM
$134K 0.01%
14,686
-11,407
-44% -$102K
GSB
199
DELISTED
GlobalSCAPE, Inc.
GSB
$130K 0.01%
13,340
-15,373
-54% -$142K
BOE icon
200
BlackRock Enhanced Global Dividend Trust
BOE
$684M
$103K 0.01%
10,974

Similar funds

Seizert Capital Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Seizert Capital Partners held 235 positions worth $1.48B, up 8.6% from $1.36B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Seizert Capital Partners withdrew a net $93.3M in Q2 2020, closing 30 positions and reducing 106 holdings. Its most notable exit was ExxonMobil, an estimated $8.04M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Seizert Capital Partners opened a new position in Dolby worth $6.34M.

  • Seizert Capital Partners's largest Q2 2020 buy was Dolby: 96,298 shares worth $6.34M.
  • Seizert Capital Partners added most to Allison Transmission in Q2 2020, an estimated $18.3M increase.
  • Seizert Capital Partners's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $19.9M.
  • Seizert Capital Partners fully exited ExxonMobil in Q2 2020, selling an estimated $8.04M.
  • Seizert Capital Partners's ten largest holdings make up 29% of its $1.48B portfolio in Q2 2020.
  • Seizert Capital Partners opened 47 new positions and closed 30 in Q2 2020.
  • Seizert Capital Partners's portfolio value rose 8.6% quarter-over-quarter to $1.48B.

Based on Seizert Capital Partners's 13F filing for Q2 2020, filed 6 Aug 2020.